Metraipolis › archive › dc_7f255aa92547
Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026 — Europe PMC PMID:42120590
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42120590
- DOI
- 10.1007/s00535-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T09:02:26.045Z
- SHA-256 of the archived text
1b99fb61dc5e233dd91f36672bed87c1c4be86a75944041a62c9f8542533415c- Stable URL of this page
https://metraipolis.com/documento/dc_7f255aa92547
How to cite
Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026 — Europe PMC PMID:42120590 — Europe PMC (en), https://europepmc.org/article/MED/42120590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7f255aa92547 (Metraipolis archive dc_7f255aa92547, sha256 1b99fb61dc5e233dd91f36672bed87c1c4be86a75944041a62c9f8542533415c)
BibTeX
@misc{dc7f255aa92547,
title = {Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026 — Europe PMC PMID:42120590},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42120590},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7f255aa92547; sha256 1b99fb61dc5e233dd91f36672bed87c1c4be86a75944041a62c9f8542533415c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42120590. Agents can read the archived copy with the MCP tool read_document.